期刊文献+

膀胱癌组织中MACC1、c-Met表达变化及意义 被引量:5

下载PDF
导出
摘要 目的观察膀胱癌组织中结肠癌转移相关基因1(MACC1)、肝细胞生长因子受体(c-Met)mRNA及其蛋白的表达变化,并探讨其临床意义。方法分别采用RT-PCR法和免疫组化法检测47例膀胱癌组织及其癌旁组织中的MACC1、c-Met mRNA及其蛋白。结果膀胱癌组织中MACC1、c-Met mRNA相对表达量分别为0.945±0.11、1.070±0.45,MACC1、c-Met蛋白阳性表达率分别为72.3%、68.0%;癌旁组织中分别为0.26±0.14、0.30±0.40、17.0%、19.1%。二者比较,P均<0.05。MACC1和c-Met蛋白表达与膀胱癌的分化程度、临床分期、淋巴结转移等有关(P均<0.05)。结论膀胱癌组织中MACC1、c-Met mRNA及其蛋白表达水平增高;c-Met通路的激活和MACC1过表达可能与膀胱癌的发生发展有关。
出处 《山东医药》 CAS 2012年第18期74-75,共2页 Shandong Medical Journal
  • 相关文献

参考文献12

  • 1Stein U, Walther W, Arh F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metas- tasis[J]. Nat Med, 2009,15( 1 ) :59-67.
  • 2刘清泉,刘青光,昝献峰,郭成,宋涛,姚英民.MACC1基因在肝细胞癌中的表达及临床意义[J].华中科技大学学报(医学版),2010,39(1):22-24. 被引量:19
  • 3吴健,张昶,朱亚宁.MACC1在膀胱癌中的表达及临床意义[J].江苏医药,2011,37(1):101-102. 被引量:8
  • 4Shimokawa H, Uramoto H, Onitsuka T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoper- ative recurrence[ J ]. J Thorac Cardiovasc Surg, 2011,141 (4) : 895 -898.
  • 5尚超,洪杨,薛一雪.MACC1基因在脑胶质瘤中的表达及其对U87细胞凋亡和增殖的影响[J].解剖科学进展,2011,17(1):1-3. 被引量:10
  • 6Shimokawa H, Uramoto H, Onitsuka T, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by analysis [ J ]. Anticancer RES, 20 1 1,31 (4) : 1141 -1145.
  • 7Boardman LA. Overexpression of MACC1 leads to downstream acti- vation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer[J]. Genome Med, 2009,1 (4) :36.
  • 8Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as me- tastatic pacemakers [ J ]. Int J Biochem Cell Biol, 2009,41 ( 12 ) : 2356-2359.
  • 9尚超,张辉,宋永胜.肾癌细胞增殖过程MACC1和c-MET调控机制的探讨[J].中华肿瘤防治杂志,2011,18(14):1065-1067. 被引量:9
  • 10Zhang RT, Shi HR, Chert ZM, et al. Effects of metastasis-associ- ated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells[ J ]. J Exp Clin Cancer Res, 2011,30 (1) :83.

二级参考文献42

  • 1Stein U, Walther W, Arlt F, et al. Maccl, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis[J]. Nat Med,2009,15(1):59- 67.
  • 2Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003,4 (12) : 915-925.
  • 3Wang R,Ferrell L D,Faouzi S,et al. Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice[J]. Cell Biol, 2001,153 (5) 1023-1034.
  • 4Bell A,Chen Q,Defrances M C,et al. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice [J ]. Oneogene, 1999,18 ( 4 ) : 887- 895.
  • 5Neaud V, Faouzi S, Guirouilh J, et al. Human hepatic myofibrob lasts increase invasiveres of hepatocellular carcinoma cells:evidence for a role of hepatocyte growth factor [J]. Hepatology, 1997,26(6) : 1458-1466.
  • 6Ueki T, Fujimoto J, Suzuki T, et al. Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinoma[J]. Hepatology, 1997,25 (4) : 862-866.
  • 7O'connell J B,Maggard M A,Liu j H,et al. A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? [J].J Surg Res,2004,121(2):214-221.
  • 8Danilkovitch-Miagkova A, Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors [J].J Clin Invest,2002,109(7) :863- 867.
  • 9Stefan M, Koch A, Mancini A, et al. Src homology 2 -containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c -Met and potentiates hepatocyte growth factor-0induced branching tubulogenesis[J]. J Biol Chem, 2001, 276(5) :3017- 3023.
  • 10Boccaccio C, Comoglio P M. Invasive growth: a MET-driven genetic programme for cancer and stem cells[J]. Nat Rev Cancer, 2006,6(8) :637-645.

共引文献33

同被引文献37

  • 1冯旺琴,崔竹梅,刘芝华,李玉军.S100A8和S100A9在子宫颈鳞癌组织中的表达[J].现代肿瘤医学,2008,16(11):1969-1972. 被引量:7
  • 2魏晓龙,郭和清.晚期膀胱癌化疗进展[J].微创泌尿外科杂志,2013,2(2):146-150. 被引量:7
  • 3王璠.基因表达影响膀胱肿瘤发生和演进的机制及其诊断和判断预后的价值[J].现代泌尿外科杂志,2005,10(4):246-248. 被引量:1
  • 4Isa F,Xie LP,Hu Z,et al.Dietary consumption and diet diversity and risk of developing bladder cancer:results from the South and East China case-control study[J].Cancer Causes Control,2013,24(5):885-895..
  • 5Liu JY,Zhang Q,Ye YL,et al.Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy[J].Int Urol Nephrol,2013,45(2):395-404..
  • 6Librenjak D,Novakovic ZS,Milostic K.Carcinoma in situ of urinary bladder:incidence,treatment and clinical outcomes during ten-year follow-up[J].Acta Clin Croat,2012,51(2):201-207..
  • 7Yu M,Guo HX,Hui C,et al.14-3-3zeta interacts with hepatocyte nuclear factor 1alpha and enhances its DNA binding and transcriptional activation[J].Biochim Biophys Acta,2013,5:23..
  • 8Man X,Zhang X,Tang J,et al.Downregulation of 14-3-3beta and 14-3-3zeta in lesions of psoriasis vulgaris[J].Clin Exp Dermatol,2013,38(4):390-395.
  • 9Nishimura Y,Komatsu S,Ichikawa D,et al.Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma[J].Br J Cancer,2013,108(6):1324-1331..
  • 10Dihazi H.Prognosis markers for metastatic renal cell carcinoma:quantitative proteomics approach[J].Expert Rev Proteomics,2013,10(1):21-24..

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部